Latest News Archive
Please select Category, Year, and then Month to display items
01 June 2023
|
Story Nicole Bongo
|
Photo Supplied
University of the Free State students participating in one of the many projects coordinated by the Engaged Scholarship Office.
To help make a change and push for sustainable development, the University of the Free State Division of Student Affairs works with communities around Bloemfontein fostering a culture of creating sustainable solutions.
Gernus Terblanche, Kovsie Support Services and Assistant Researcher in the Division says, ‘it is important for the university to be actively involved in the community as it makes up such a large portion of the Bloemfontein and students also
represent many different communities on and off- campus.’
Terblanche said: “As an educational institution it is vital for the UFS to support and guide students towards creating innovative solutions; both local and globally. Our experience is that students often come up with real solutions that can
make a real impact in the lives of real people – and it would be crucial to support such initiatives.”
The office has worked with BloemShelter, VermiVillage, GAP Equip, National Hospital and as part of the programmes of 2022 also with Lighuis, Talita Cumi, ROC Kids and the Universitas Neighborhood association. “We are also very fortunate to have,
Shanen Emam, Miss Free State 2023 as one of our students that are involved with our programmes,” added Terblanche.
One of the students involved is Prince Sijane, Bloemfontein Campus Student Representative Council member responsible for Civic and Social Responsibility when asked why student participation is important, he said, “By actively participating in
initiatives that address social issues or promote community well-being, students become more aware of the challenges faced by society.”
Tereblanche said: “The produce of these gardens addresses hunger and malnutrition amongst students on campus. KovsieACT also facilitates an eco-vehicle project during which student teams learn how to build electric vehicles powered by solar charging
stations. This project is aimed at developing skills appropriate to the 4th Industrial Revolution and sustainable resources development including clean and green energy.”
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004